US FDA explains difference between device recalls and product enhancements
This article was originally published in Clinica
Executive Summary
The US Food and Drug Administration is inviting feedback on a draft guideline that clarifies when a potential change to a medical device should result in a recall and when such a change should be classified as a product enhancement. The guideline also specifies the reporting requirements applicable in both cases.